TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.16M2012: -$10.20M2013: -$22.76M2014: -$36.22M2015: -$50.04M2016: -$76.15M2017: -$168.98M2018: -$204.59M2019: -$93.10M2020: -$121.40M2021: -$226.73M2022: -$179.50M2023: -$155.56M2024: $54.40M2025: $60.27M$60.27M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$60.27M+10.8%
2024$54.40M+135.0%
2023-$155.56M+13.3%
2022-$179.50M+20.8%
2021-$226.73M-86.8%
2020-$121.40M-30.4%
2019-$93.10M+54.5%
2018-$204.59M-21.1%
2017-$168.98M-121.9%
2016-$76.15M-52.2%
2015-$50.04M-38.1%
2014-$36.22M-59.2%
2013-$22.76M-123.0%
2012-$10.20M-0.4%
2011-$10.16M—